Biotechnology has been a significant differentiator for our business and has helped us blaze new paths, and set goals that have impacted human life. Our biotechnology programme is geared towards a single objective - making high-quality affordable products that will take the benefits of this amazing science, to a large section of patients.
With very rich experience in mastering biotechnology research, we have built a competent organization of skilled biotechnologists and ‘concept to market’ capabilities, in all facets of development and manufacture of recombinant biopharmaceuticals.
Unimark’s comprehensive biotechnology capabilities include:
- Gene cloning
- Development of production strains
- Expression of proteins in all major expression systems - yeast, bacterial and mammalian cells
- Downstream processing and development